SecBot SecBot
8-K ·Filed Nov 12, 2026

IRTC

iRhythm Holdings, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4d 21h ago SEC0001104659-26-125580
8-K context-dependent: Items 7.01, 8.01
Actionable Insight • Neutral

The buyback authorization is discretionary and non-binding; actual repurchase execution depends on market conditions and cash flow. Monitor future 10-Qs for actual share repurchase activity and cash balance trends.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$93.56
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.76%
T+1 · $91.91
Vs SPY
−1.40%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $93.56entry
  2. T+1 · 4d ago −1.76%α −1.40% · $91.91
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

iRhythm Holdings announced a $200 million share repurchase program approved by its board on November 10, 2026. The program may be executed through open market or private transactions and will be funded with existing cash and cash from operations. The filing also references the recently acquired VitalConnect business as a growth opportunity.

Key Facts

  • Board approved share repurchase program on November 10, 2026
  • Authorization to purchase up to $200 million of outstanding common stock
  • Repurchases may be made in open market, privately negotiated transactions, or accelerated share repurchase transactions
  • Funding from existing cash and cash equivalents and ongoing cash from operations
  • Program does not obligate the company to repurchase any particular dollar amount or number of shares
  • Program may be modified, suspended or terminated at any time at the board's discretion
  • Press release references recently acquired VitalConnect business as a growth opportunity

Financial Impact

$200 million share repurchase authorization, representing approximately 6.7% of the $3.0B market cap

dilutioncash

Risk Factors

  • Program is discretionary and may not be executed in full or at all
  • Funding depends on existing cash and ongoing operations, which could limit buyback capacity
  • No specific timeline or commitment to repurchase any shares

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-125580
Document: tm2629543d1_ex99-1.htm0001104659-26-125580
Document: 0001104659-26-125580-index-headers.html0001104659-26-125580
Document: 0001104659-26-125580-index.html0001104659-26-125580
Document: 0001104659-26-125580.txt0001104659-26-125580

Track record

31 reports on IRTC

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
  2. Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  4. Nov 12, 20264d ago 8-K Neutral 4/10 Viewing Entry $93.56 Now $90.83 −2.92% settles Nov 19
  5. Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  6. Nov 5, 202611d ago 8-K Mixed 6/10 No price data
  7. Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
  9. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
  10. Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens in 6h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026